BridgeBio Pharma
na fa'atupula'ia fa'atauga ina ua lipotia mai e le kamupani biopharmaceutical i'uga lelei i se fa'ata'ita'iga fa'ata'ita'i o le Vaega lua mo se togafitiga fa'ata'ita'i mo le achondroplasia, o le ituaiga sili ona taatele o fa'ama'i pupu'u vae.
I le Aso Gafua, na taʻua ai e BridgeBio (ticker: BBIO) i se faʻasalalauga talafou e faʻapea, o lana vailaʻau faʻataʻitaʻiga Infigratinib na faʻaalia ai le faʻaleleia o le 3.03 senitimita i tausaga taʻu o le maualuga o le saoasaoa, poʻo le maualuga o le maualuga, i se suʻesuʻega e aofia ai tamaiti 10.
Punavai: https://www.barrons.com/articles/bridgebio-stock-dwarfism-drug-biomarin-40cc3e70?siteid=yhoof2&yptr=yahoo